Effect of insulin on the inflammatory and acute phase response after burn injury

Critical Care Medicine

Volumn 35, Issue 9 SUPPL., 2007, Pages

  Jeschke, Marc G ^a   Boehning, Darren F ^a   Finnerty, Celeste C ^a   Herndon, David N ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Acute phase response; Burn injury; Inflammatory response; Insulin; Liver

Indexed keywords

CYTOKINE; INSULIN; TRANSCRIPTION FACTOR;

ACUTE PHASE RESPONSE; BURN; CONFERENCE PAPER; CRITICAL ILLNESS; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN TREATMENT; LIVER FUNCTION; LIVER STRUCTURE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; THERMAL INJURY;

ACUTE-PHASE REACTION; ANIMALS; BURNS; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSURIA; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN; LIVER; MITOCHONDRIA;

EID: 34548180637     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000282027.10288.10     Document Type: Conference Paper

References (29)

1. Finnerty CC, Herndon DN, Przkora R, et al: Cytokine expression profile over time in severely burned pediatric patients. Shock 2006; 26:13-19
2. Tracey KJ, Fong Y, Hesse DG, et al: Anti-cachectin/ TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662-664
3. Tracey KJ, Lowry SF, Fahey TJ III, et al: Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet 1987; 164:415-422
4. Moshage H: Cytokines and the hepatic acute phase response. J Pathol 1997; 181:257-266
5. Gore DC, Ferrando A, Barnett J, et al: Influence of glucose kinetics on plasma lactate concentration and energy expenditure in severely burned patients. J Trauma 2000; 49:673-677
6. Wolfe RR, Miller HI, Spitzer JJ: Glucose and lactate kinetics in burn shock. Am J Physiol 1977; 232:E415-E418
7. Carter EA, Burks D, Fischman AJ, et al: Insulin resistance in thermally-injured rats is associated with post-receptor alterations in skeletal muscle, liver and adipose tissue. Int J Mol Med 2004; 14:653-658
8. Ikezu T, Okamoto T, Yonezawa K, et al: Analysis of thermal injury-induced insulin resistance in rodents: Implication of postreceptor mechanisms. J Biol Chem 1997; 272:25289-25295
9. Gore DC, Chinkes D, Heggers J, et al: Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 51:540-544
10. Gore DC, Chinkes DL, Hart DW, et al: Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med 2002; 30:2438-2442
11. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367
12. Van den Berghe G: Insulin therapy for the critically ill patient. Clin Cornerstone 2003; 5:56-63
13. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461
14. van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367
15. Ellger B, Debaveye Y, Vanhorebeek I, et al: Survival benefits of intensive insulin therapy in critical illness: Impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 2006; 55:1096-1105
16. Ferrando AA, Chinkes DL, Wolf SE, et al: A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 1999; 229:11-18
17. Pierre EJ, Barrow RE, Hawkins HK, et al: Effects of insulin on wound healing. J Trauma 1998; 44:342-345
18. Thomas SJ, Morimoto K, Herndon DN, et al: The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 2002; 132:341-347
19. Zhang XJ, Chinkes DL, Wolf SE, et al: Insulin but not growth hormone stimulates protein anabolism in skin would and muscle. Am J Physiol 1999; 276:E712-E720
20. Jeschke MG, Mlcak RP, Herndon DN: Morphologic changes of the liver after a severe thermal injury. Shock 2007, In Press
21. Ward S, Sotsios Y, Dowden J, et al: Therapeutic potential of phosphoinositide 3-kinase inhibitors. Chem Biol 2003; 10:207-213
22. Wetzker R, Rommel C: Phosphoinositide 3-kinases as targets for therapeutic intervention. Curr Pharm Des 2004; 10:1915-1922
23. Williams DL, Li C, Ha T, et al: Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J Immunol 2004; 172:449-456
24. Dionne MS, Pham LN, Shirasu-Hiza M, et al: Akt and FOXO dysregulation contribute to infection-induced wasting in Drosophila. Curr Biol 2006; 16:1977-1985
25. Jeschke MG, Klein D, Herndon DN: Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 2004; 239:553-560
26. Jeschke MG, Einspanier R, Klein D, et al: Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 2002; 8:443-450
27. Klein D, Schubert T, Horch RE, et al: Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg 2004; 240:340-349
28. Jeschke MG, Klein D, Bolder U, et al: Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 2004; 145:4084-4093
29. Jeschke MG, Rensing H, Klein D, et al: Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol 2005; 42:870-879